Quick Takeaways
- James E. Flynn filed SCHEDULE 13G for Cogent Biosciences, Inc. Common Stock (COGT).
- Disclosed ownership: 6.5%.
- Date of event: 07 Jul 2025.
James E. Flynn - 07 Jul 2025 SCHEDULE 13G Report for Cogent Biosciences, Inc. Common Stock (COGT)
- Filing Manager
- James E. Flynn
- Reporting Manager
- Deerfield Mgmt, L.P.
- Symbol
- COGT
- Shares outstanding
- 139,493,344 shares
- Disclosed Ownership
- 9,053,118 shares
- Ownership
- 6.5%
- Form type
- SCHEDULE 13G
- Filing time
- 11 Jul 2025, 08:19:17 UTC
- Date of event
- 07 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"James E. Flynn disclosed 6.5% ownership in Cogent Biosciences, Inc. Common Stock (COGT) on 07 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 11 Jul 2025, 08:19.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deerfield Mgmt, L.P. | 6.5% | 9,053,118 | 9,053,118 | 0 | /s/ Jonathan Isler | Jonathan Isler, Attorney-In-Fact | |
| Deerfield Management Company, L.P. | 6.5% | 9,053,118 | 9,053,118 | 0 | /s/ Jonathan Isler | Jonathan Isler, Attorney-In-Fact | |
| Deerfield Partners, L.P. | 6.5% | 9,053,118 | 9,053,118 | 0 | /s/ Jonathan Isler | Jonathan Isler, Attorney-In-Fact | |
| James E. Flynn | 6.5% | 9,053,118 | 9,053,118 | 0 | /s/ Jonathan Isler | Jonathan Isler, Attorney-In-Fact |